# Nucleus Capital

> Nucleus Capital is a VC fund backing Biotechnology and Food and Beverage. See 48 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Berlin, Germany
- Total investments: 48
- Last investment: Jun 2026
- Lead investor: 33%
- Last fund: Nov 2024
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/66309282/
- Website: http://www.nucleus-capital.com/

Nucleus Capital is a VC fund in Berlin focused on Biotechnology and Food and Beverage. Fueling pioneers, turning bold science into planetary resilience. A first check deep-tech VC focused on Programmable Biology (Synbio & TechBio), Food Technology and Green Industrials.

## Contacts

5 contacts available for Nucleus Capital. Shizune tracks 4 team members at Nucleus Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/nucleus-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3M–$8M |
| Pre-Seed | $486k–$3.8M |
| Series A | $15M–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 14 | 29% |
| Food and Beverage | 6 | 13% |
| Agriculture | 4 | 8% |
| Life Science | 4 | 8% |
| Manufacturing | 4 | 8% |

54 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 26 | 54% |
| Seed | 13 | 27% |
| Series A | 2 | 4% |
| Convertible Note | 2 | 4% |
| Venture - Series Unknown | 1 | 2% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 11 | 23% |
| United Kingdom | 8 | 17% |
| United States | 7 | 15% |
| The Netherlands | 3 | 6% |
| Italy | 1 | 2% |

11 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Carolina Villa | Principal | 0 | https://shizune.co/investors/profile/dr-carolina-villa |
| Isabella Fandrych | Co-Founder & GP | 2 | https://shizune.co/investors/profile/isabella-fandrych |
| Martin Weber | Investor | 4 | https://shizune.co/investors/profile/martin-weber-5bfc |
| Maximilian Schwarz | Founder & GP | 3 | https://shizune.co/investors/profile/maximilian-a-bade |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Apoha | Stealth stage start-up | $36M | Venture - Series Unknown | Jun 03, 2026 |  |
| Triple Bio | Triple Bio is a biotech startup focused on improving productivity and sustainability in dairy and beef production using biological and data‑driven technologies. | $1.7M | Pre-Seed | May 20, 2026 |  |
| Bindbridge | Bindbridge is an AgTech company that applies artificial intelligence to discover and design molecular glues for crop protection. The company develops computational models that identify and optimize small molecules capable of selectively binding target proteins, enabling novel modes of action against weeds and crop diseases. Its platform integratesAI-driven drug discovery techniques with plant biology and agronomic research to generate candidates intended to improve efficacy while reducing off-target impact. Bindbridge advances these molecules through laboratory validation and early-stage development processes focused on safety, performance, and environmental considerations. The company collaborates with agricultural and crop science partners to evaluate applications across herbicide and fungicide use cases. Through its AI-enabled discovery approach, Bindbridge works to expand the range of crop protection tools available for modern agriculture. | $3.8M | Pre-Seed | Mar 03, 2026 |  |
| Biographica | Biographica is a computational biology company that develops software tools and platforms to support genomic data analysis, interpretation, and visualization for research and clinical applications. Its solutions are designed to help scientists, clinicians, and bioinformaticians process complex genomic datasets, annotate genetic variants, andexplore biological insights through integrated workflows and interactive visualizations. The company’s platform combines data management, algorithmic analysis, and graphical interfaces to streamline tasks such as sequence alignment, variant calling, functional interpretation, and cohort comparison. Biographica’s tools support interoperability with common bioinformatics formats and pipelines, enabling users to integrate genomic workflows with existing research infrastructure. The company also provides APIs and developer tools to allow custom integration, automation, and extension of analytic capabilities within broader computational environments. Its offerings are used across life sciences research, translational projects, and precision medicine initiatives that require scalable, interpretable genomic data analysis. | $9.5M | Seed | Jan 07, 2026 |  |
| Endolith | Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition. | $16.5M | Series A | Nov 05, 2025 |  |
| Telura | Telura is a deep-tech business that uses next-generation drilling to enable geothermal energy everywhere. Telura creates electric impulse drilling technology, which breaks rock from within using high-voltage pulses. | $4.7M | Pre-Seed | Oct 01, 2025 |  |
| Vosbor | Vosbor is a digital grain & oilseed trading platform providing a spot and forward market to reconcile trade data & securely share documents. |  | Convertible Note | Sep 16, 2025 |  |
| ScienceMachine | ScienceMachine is an AI startup accelerating biotech data analysis with a fully autonomous agent, | $3.5M | Pre-Seed | Jul 09, 2025 |  |
| Koppie | Koppie is a company has developed a patent-pending fermentation and roasting technology that transforms locally sourced pulses | $1.6M | Pre-Seed | Jun 26, 2025 |  |
| Bindbridge | Bindbridge is an AgTech company that applies artificial intelligence to discover and design molecular glues for crop protection. The company develops computational models that identify and optimize small molecules capable of selectively binding target proteins, enabling novel modes of action against weeds and crop diseases. Its platform integratesAI-driven drug discovery techniques with plant biology and agronomic research to generate candidates intended to improve efficacy while reducing off-target impact. Bindbridge advances these molecules through laboratory validation and early-stage development processes focused on safety, performance, and environmental considerations. The company collaborates with agricultural and crop science partners to evaluate applications across herbicide and fungicide use cases. Through its AI-enabled discovery approach, Bindbridge works to expand the range of crop protection tools available for modern agriculture. | $3.8M | Pre-Seed | Jun 02, 2025 |  |

10 of 48 investments shown.

## Co-investors
- [Nucleus Capital](https://shizune.co/investors/profile/k16-ventures) — VC Fund, 29 deals together
- [Juniper](https://shizune.co/investors/profile/climate-capital-bio) — VC Fund, 4 deals together
- [First Momentum Ventures](https://shizune.co/investors/profile/first-momentum-ventures) — VC Fund, 4 deals together
- [Mudcake](https://shizune.co/investors/profile/mudcake) — VC Fund, 4 deals together
- [Pale blue dot](https://shizune.co/investors/profile/pale-blue-dot-3a83) — VC Fund, 4 deals together
- [Possible Ventures](https://shizune.co/investors/profile/possible-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Food and Beverage Investors in Europe](https://shizune.co/investors/food-and-beverage-investors-europe)
- [Food and Beverage VC Funds in Europe](https://shizune.co/investors/food-and-beverage-vc-funds-europe)
- [Gaming VC Funds in Germany](https://shizune.co/investors/gaming-vc-funds-germany)
- [Food and Beverage VC Funds in Germany](https://shizune.co/investors/food-and-beverage-vc-funds-germany)
- [Food and Beverage Investors in Germany](https://shizune.co/investors/food-and-beverage-investors-germany)
- [Gaming Investors in Germany](https://shizune.co/investors/gaming-investors-germany)

## FAQ

### What does Nucleus Capital invest in?

Nucleus Capital invests primarily in Biotechnology, Food and Beverage and Agriculture startups, most often at Pre-Seed and Seed stage. Most of the 48 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Nucleus Capital's check size?

Nucleus Capital typically joins rounds of $3M–$8M at Seed, $486k–$3.8M at Pre-Seed and $15M–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nucleus Capital participates in.

### How do I contact Nucleus Capital?

Public channels for Nucleus Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Nucleus Capital?

The team at Nucleus Capital includes Carolina Villa (Principal), Isabella Fandrych (Co-Founder & GP) and Martin Weber (Investor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co